Memantine: Completed Phase IIb study enrollment

Neurobiological Technologies Inc. (NTII), Richmond, Calif. Product: Memantine Business: Neurological Therapeutic category: Neurotransmission Target: NMDA receptor Description: NMDA receptor mod...